The ESMO Guidelines: Real World Cases Webinar – Uveal Melanoma 2026, organized by the European Society for Medical Oncology (ESMO), will take place online on November 25, 2026, at 18:30 CET. The educational session will bring together oncology experts to explore evidence-based approaches to the diagnosis, treatment and management of uveal melanoma through a real-world clinical case.

Uveal melanoma is a rare and biologically distinct cancer that presents significant clinical challenges, particularly in metastatic disease. The webinar will examine current ESMO Clinical Practice Guideline recommendations, recent therapeutic advances, and the role of molecular profiling in guiding treatment decisions. Particular attention will be given to emerging immunotherapeutic approaches and the clinical application of tebentafusp in eligible patients.

Through a case presentation, expert guideline review and multidisciplinary discussion, participants will explore practical challenges in managing uveal melanoma and consider how evolving scientific evidence can inform clinical decision-making. The session aims to support guideline implementation and improve the quality of care for patients with this rare malignancy.